Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
about
Early biomarkers of joint damage in rheumatoid and psoriatic arthritisNeuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease.The therapeutic potential of interleukin-6 hyperagonists and antagonists.Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritisThe soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.Sexual Dimorphisms of Adrenal Steroids, Sex Hormones, and Immunological Biomarkers and Possible Risk Factors for Developing Rheumatoid Arthritis.Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigueThe need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.Fenofibrate inhibits reactive amyloidosis in mice.Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis.
P2860
Q28083506-B2FE38B3-FE8E-45AD-B236-6167E19578B5Q34340516-5D0D51D1-3B22-4903-84E5-1F7319AC7471Q34430168-99A73D9C-FAFF-4361-B5C2-6B9B3B905641Q35609892-A4FE32F3-BBDD-4EA2-96E3-C3AD302D8216Q35829699-2BD2FD73-AB17-4886-B670-7ACFE386A4E3Q35840842-333F9201-F1B9-4E3C-894D-B49055AC97ADQ36360396-3577B0B2-0E84-49F0-B91B-EC12A7699746Q36398044-3C71434C-CABD-4D20-B639-A3E9C5464C65Q36790324-4AB9F3CC-7F9C-4D9F-9555-702262FBBD14Q38393444-86EC4D4F-51FE-49E8-8901-4951A0DC1B20Q42840040-D449D93F-47C4-4BEA-AA41-8AF5B20433A4Q43988928-A2B9A353-E7E5-43C0-9B8E-A75ADC481152Q44062265-B8615DC1-89BB-46C5-BEAC-5BD76AFE4D90Q54365032-70352B0E-42A5-4CCD-8838-F8B34A2F665E
P2860
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Clinical significance of inter ...... three year prospective study.
@ast
Clinical significance of inter ...... three year prospective study.
@en
Clinical significance of inter ...... three year prospective study.
@nl
type
label
Clinical significance of inter ...... three year prospective study.
@ast
Clinical significance of inter ...... three year prospective study.
@en
Clinical significance of inter ...... three year prospective study.
@nl
prefLabel
Clinical significance of inter ...... three year prospective study.
@ast
Clinical significance of inter ...... three year prospective study.
@en
Clinical significance of inter ...... three year prospective study.
@nl
P2093
P2860
P356
P1476
Clinical significance of inter ...... three year prospective study.
@en
P2093
Limburg PC
van Leeuwen MA
van Riel PL
van Rijswijk MH
P2860
P304
P356
10.1136/ARD.54.8.674
P407
P577
1995-08-01T00:00:00Z